What I have: an HPLC purity test · aggregation · oral semaglutide.
I want to know what the trade-off actually is rather than which option is fashionable.
I would rather have a defensible reason than a marginal improvement.
What does each option buy me, and what does it cost me?
It helps to be literal here: what a useful certificate carries is debatable, but there are certain fields that almost no research-grade certificate includes despite their being standard in pharmaceutical work.
The laboratory name and accreditation status can be checked in real time against the testing service's own register, and that two-minute check catches substituted certificates.
| Test | Answers | Does NOT answer |
|---|---|---|
| RP-HPLC, area % | What fraction of detected material is the target | How much target is present |
| Quantified content | Milligrams of peptide per vial | What the impurities are |
| ESI-MS identity | Whether the molecular weight matches | Purity, or isomeric substitution |
| Peptide mapping | Sequence, localised to a fragment | Quantity |
| Karl Fischer | Water content of the solid | Solvent content |
| LAL endotoxin | Pyrogen load in EU/mg | Sterility |
| Sterility test | Growth in defined media over 14 days | Endotoxin, or bioburden count |
Test results from a material supplier are different from independent results in ways that matter for interpretation, even if both are accurate.
Industry guidance on this topic is consistent because it comes from first principles rather than convention.
Worth noting that none of this is medical advice, and a compound sold for research use carries no regulatory approval in any jurisdiction.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemThe relevant detail is that before anything else, check that the lot number on the certificate matches the vial in your hand — that traces back to your material and not to some other lot from some other date.
The field you have least reason to trust is the one that looks most impressive, because appearance and accuracy are not correlated.
Worth being precise here: batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.
Pharmacopoeial standards require method validation steps that research-grade certificates almost never claim to meet, and the absence of that claim is itself information.
The limitation is cost — truly rigorous testing on every lot is expensive enough that most people do not do it, which is exactly why the variation matters.
My working rule is that a document without a lot number, a method section and a test date is marketing.
The underlying point is that a certificate without a method section is giving you a claim rather than a measurement, and claims are not evidence.
Lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.
To be exact about it, writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.
The caveat is that a certificate is not a guarantee, it is a data point, and treating it as anything else is asking for disappointment.
If the certificate does not trace to your vial, it is not evidence about your vial.
Stated carefully, the certificate is not the answer to your question; it is a data point that you need to combine with other information to build an answer.
A method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.
Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.
One qualification: a single result from a single vial at a single time is a point estimate with no error bar, and no amount of decimal places changes that.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
Specifically, most certificates are written to look impressive rather than to be informative, and it is worth being sceptical of that gap.
The certificate is a snapshot and nothing else — it tells you about the material on one day from one sample of one lot, and extrapolation beyond that requires logic.
The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.
My working rule is that a document without a lot number, a method section and a test date is marketing.
edited 9 Jul 2025 by Dr_Nadia_Farsi — tightened the wording; no substantive change
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.